344 related articles for article (PubMed ID: 7907613)
1. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.
Lynch DA; Clarke AM; Jackson P; Axon AT; Dixon MF; Quirke P
J Clin Pathol; 1994 Feb; 47(2):122-5. PubMed ID: 7907613
[TBL] [Abstract][Full Text] [Related]
2. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in type C gastritis affecting the intact stomach.
Dowall JE; Willis P; Prescott R; Lamonby S; Lynch DA
J Clin Pathol; 2000 Oct; 53(10):784-7. PubMed ID: 11064674
[TBL] [Abstract][Full Text] [Related]
4. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
Yu CC; Dublin EA; Camplejohn RS; Levison DA
Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
Tinnemans MM; Lenders MH; ten Velde GP; Wagenaar SS; Blijham GH; Ramaekers FC; Schutte B
Virchows Arch; 1995; 427(3):295-301. PubMed ID: 7496600
[TBL] [Abstract][Full Text] [Related]
8. Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinoma and adjacent normal gastric tissue.
Schipper DL; Wagenmans MJ; Peters WH; Wobbes T; Wagener DJ
Anticancer Res; 2000; 20(2A):707-14. PubMed ID: 10810344
[TBL] [Abstract][Full Text] [Related]
9. Proliferation cell nuclear antigen (clone 19A2) correlates with 5-bromo-2-deoxyuridine labelling in human colonic epithelium.
Weisgerber UM; Boeing H; Nemitz R; Raedsch R; Waldherr R
Gut; 1993 Nov; 34(11):1587-92. PubMed ID: 7902310
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
11. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
12. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
13. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
14. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
16. PCNA/cyclin defined proliferative activity of epithelial cells in normal gastric mucosa and in chronic gastritis.
Bielicki D; Markiewski M; Marlicz K; Domaga+a W
Patol Pol; 1993; 44(2):75-8. PubMed ID: 8103592
[TBL] [Abstract][Full Text] [Related]
17. Sustained increase in gastric antral epithelial cell proliferation despite cure of Helicobacter pylori infection.
El-Zimaity HM; Graham DY; Genta RM; Lechago J
Am J Gastroenterol; 2000 Apr; 95(4):930-5. PubMed ID: 10763940
[TBL] [Abstract][Full Text] [Related]
18. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
Coltrera MD; Gown AM
J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
Harrison RF; Reynolds GM; Rowlands DC
J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
